Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature. [PDF]
Peng J +8 more
europepmc +1 more source
Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement. [PDF]
Liphaus BL +5 more
europepmc +1 more source
Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
Falcini FF +8 more
doaj +1 more source
STAT4 gene polymorphism in two major autoimmune diseases (multiple sclerosis and juvenile onset systemic lupus erythematosus) and its relation to disease severity. [PDF]
Nageeb RS +5 more
europepmc +1 more source
Breaking the Storm: Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome as the First Manifestation of Systemic Lupus Erythematosus/Mixed Connective Tissue Disease in an Adolescent Successfully Treated With Anakinra. [PDF]
Alhasan R +5 more
europepmc +1 more source
An investigation of the association between Juvenile rheumatic disease and growth: a retrospective matched cohort study. [PDF]
Elango N, McCann LJ, Hughes DM.
europepmc +1 more source
Systemic Lupus Erythematosus and the Risk of Coeliac Disease: Substantial Discrepancies Among Studies Highlight a Significant Research Gap. [PDF]
Liapis NM +4 more
europepmc +1 more source
Nailfold capillary phenotypes distinguish juvenile myositis subtypes and associate with disease activity. [PDF]
McClellan N +7 more
europepmc +1 more source

